The media laughed.— Charles V Payne (@cvpayne) April 27, 2020
AYTU shares +37% today
Aytu BioScience has signed an exclusive licensing deal with Cedars-Sinai. The center has developed and is testing a UV-A “Healight” designed to be inserted via a catheter inside the trachea to kill pathogens, including the coronavirus.
An Experimental Ultraviolet Light Treatment for Covid-19 Takes Political Heat - WSJ https://t.co/oLki7IWiKb— Josh Disbrow (@josh_disbrow) April 27, 2020
